RTW Investments’s Immunovant IMVT Stock Holding History

RTW Investments’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$78.9M	Sell	3,177,849 -1	-0%	-$26	0.79%	35
2025 Q4	$80.8M	Buy	+3,177,850	New	+$70.9M	0.81%	36
2025 Q1	–	Sell	-530,614	Closed	-$13.1M	–	75
2024 Q4	$13.1M	Buy	+530,614	New	+$15.1M	0.2%	53
2021 Q2	–	Sell	-6,356,743	Closed	-$102M	–	117
2021 Q1	$102M	Sell	6,356,743 -1,235,510	-16%	-$32.6M	1.59%	20
2020 Q4	$351M	Buy	7,592,253 +81,841	+1%	+$3.78M	5.88%	2
2020 Q3	$264M	Buy	7,510,412 +1,793,230	+31%	+$53.9M	6.36%	2
2020 Q2	$139M	Buy	5,717,182 +1,291,076	+29%	+$27.7M	3.92%	6
2020 Q1	$65.9M	Hold	4,426,106	–	–	2.84%	11
2019 Q4	$66M	Buy	+4,426,106	New	+$49.6M	2.49%	12

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

RTW Investments's IMVT Position: Q1 2026 in Review

RTW Investments reduced its Immunovant (IMVT) stake by 0% in Q1 2026, selling an estimated $26 and leaving 3,177,849 shares worth $78.9M. The position accounts for 0.79% of the portfolio, ranked #35.

RTW Investments first reported a position in IMVT in Q4 2019 and has held it in 9 quarters since. The position peaked at $351M in Q4 2020. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

RTW Investments held 3,177,849 shares of Immunovant worth $78.9M as of Q1 2026.
RTW Investments sold 1 Immunovant share in Q1 2026, an estimated $26.
Immunovant made up 0.79% of RTW Investments's portfolio in Q1 2026, its #35 holding.
RTW Investments first reported a position in Immunovant in Q4 2019 and has held it in 9 quarters since.
RTW Investments's Immunovant position peaked at $351M in Q4 2020.
215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on RTW Investments's 13F filing for Q1 2026, filed 15 May 2026.